BSc (Hons), MBChB, MRCP, DPhil
Consultant Hepatologist & Senior Lecturer in Gastroenterology & Hepatology, JR Hospital, Oxford.
- Wellcome Trust Clinical Research Fellow, University of Oxford, Oxford, UK.
Emma Culver is a Consultant Hepatologist and Senior Lecturer at the Translational Gastroenterology Unit, John Radcliffe Hospital in Oxford, with an interest in immune mediated liver diseases including IgG4-related disease, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis.
She set up and co-ordinated the IgG4-RD Study in Oxford during her Academic Clinical Fellowship (2010) and Wellcome Trust Clinical Research Fellowship (DPhil 2011-2015). Her PhD work focussed on the natural history and immunological drivers of IgG4-RD. Her NIHR BRC Oxford Clinical Lectureship (2018-) centred on the fibrotic mechanisms of this disease. She runs the Oxford Autoimmune Liver Disease service with specialist IgG4, PSC and autoimmune liver clinics, and runs a regional autoimmune liver disease MDT, and a national Oxford-London IgG4 MDT.
She is Chair of UK IgG4 and on the Steering Committee for UK PSC, and a member of the International IgG4-RD, PSC and AIH Study Groups.
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL. et al, (2020), Liver international : official journal of the International Association for the Study of the Liver, 40, 2744 - 2757
Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses.
Unger P-PA. et al, (2020), European journal of immunology, 50, 1113 - 1125
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.
Löhr J-M. et al, (2020), United European gastroenterology journal, 8, 637 - 666
Review of primary sclerosing cholangitis with increased IgG4 levels.
Manganis CD. et al, (2020), World journal of gastroenterology, 26, 3126 - 3144
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.
Goodchild G. et al, (2020), Clinical medicine (London, England), 20, e32 - e39